Muscle wastage in heart failure: Orphan of the heart failure

International Journal of Cardiology

Volumn 135, Issue 2, 2009, Pages 233-236

  Celik, Turgay ^a   Iyisoy, Atila ^a   Celik, Murat ^a   Yuksel, U Cagdas ^b   Isik, Ersoy ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Sarikamis Army District Hospital Turkey   (Turkey)

Author keywords

Cardiac cachexia; Cytokines; Heart failure; Inflammation; Muscle wastage

Indexed keywords

INFLIXIMAB; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CACHEXIA; CYTOKINE PRODUCTION; DIETARY INTAKE; GASTROINTESTINAL DISEASE; HEART FAILURE; HUMAN; LEG MUSCLE; METABOLIC DISORDER; MUSCLE ATROPHY; PRIORITY JOURNAL;

CACHEXIA; HEART FAILURE; HUMANS; MUSCULAR ATROPHY;

EID: 67349202466     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.12.121     Document Type: Article

References (30)

1. Cuoco L., Vescovo G., Castaman R., et al. Skeletal muscle wastage in Crohn's disease: a pathway shared with heart failure?. Int J Cardiol 127 (2008) 219-227
2. Colucci W.S. Nitric oxide, other hormones, cytokines, and chemokines in heart failure. In: Rose B.D. (Ed). UpToDate (2006), UpToDate, Wellesley
3. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J.B., and Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27 (1996) 1201-1206
4. Testa M., Yeh M., Lee P., et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 28 (1996) 964-971
5. Mohler E., Sorenson L.C., Ghali J.K., et al. Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial. J Am Coll Cardiol 30 (1997) 35-41
6. Deswal A., Petersen N.J., Feldman A.M., Young J.B., White B.G., and Mann D.L. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the vesnarinone trial (VEST). Circulation 103 (2001) 2055-2059
7. Ferrari R., Bachetti T., Confortini R., et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92 (1995) 1479-1486
8. Rauchhaus M., Doehner W., Francis D.P., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102 (2000) 3060-3067
9. Vasan R.S., Sullivan L.M., Roubenoff R., et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 107 (2003) 1486-1491
10. Kapadia S.R., Yakoob K., Nader S., Thomas J.D., Mann D.L., and Griffin B.P. Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. J Am Coll Cardiol 36 (2000) 208-212
11. Feldman A.M., Combes A., Wagner D., et al. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 35 (2000) 537-544
12. Torre-Amione G., Kapadia S., Lee J., et al. Tumor necrosis factor alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93 (1996) 704-711
13. Kapadia S.R., Oral H., Lee J., Nakano M., Taffet G.E., and Mann D.L. Hemodynamic regulation of tumor necrosis factor-alpha and protein expression in adult feline myocardium. Circ Res 81 (1997) 187-195
14. Niebauer J., Volk H.-D., Kemp M., et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353 (1999) 1838-1842
15. Bozkurt B., Kribbs S.B., Clubb F.J., et al. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97 (1998) 1382-1391
16. Nakamura K., Fushimi K., Kouchi H., Mihara, et al. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 98 (1998) 794-799
17. Anker S.D., and Coats A.J. How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Int J Cardiol 86 (2002) 123-130
18. Chung E.S., Packer M., Lo K.H., Fasanmade A.A., and Willerson J.T. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107 (2003) 3133-3140
19. Tsutamoto T., Hisanaga T., Wada A., et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 31 (1998) 391-398
20. Kokkinos P.F., Choucair W., Graves P., Papademetriou V., and Ellahham S. Chronic heart failure and exercise. Am Heart J 140 (2000) 21-28
21. Clark A.L., Poole-Wilson P.A., and Coats A.J.S. Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol 28 (1996) 1092-1102
22. Chati Z., Zannad F., Jeandel C., et al. Physical deconditioning may be the mechanism for the skeletal muscle energy phosphate metabolism abnormalities in chronic heart failure. Am Heart J 131 (1996) 560-566
23. Vescovo G., Volterrani M., Zennaro R., et al. Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart 84 (2000) 431-437
24. Duscha B.D., Kraus W.E., Keteyian S.J., et al. Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations. J Am Coll Cardiol 33 (1999) 1956-1963
25. Tsutsui H., Ide T., Hayashidani S., et al. Enhanced generation of reactive oxygen species in the limb skeletal muscles from a murine infarct model of heart failure. Circulation 104 (2001) 134-136
26. Mancini D.M., Coyle E., Coggan A., et al. Contribution of intrinsic skeletal muscle changes to 31P-NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation 80 (1989) 1338-1346
27. De Sousa E., Veksler V., Bigard X., Mateo P., and Ventura-Clapier R. Heart failure affects mitochondrial but not myofibrillar intrinsic properties of skeletal muscle. Circulation 102 (2000) 1847-1853
28. Schaufelberger M., Eriksson B.O., Grimby G., Held P., and Swedberg K. Skeletal muscle alterations in patients with chronic heart failure. Eur Heart J 18 (1997) 971-980
29. Riede U.N., Forstermann U., and Drexler H. Inducible nitric oxide synthase in skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 32 (1998) 964-969
30. Walsh J.T., Andrews R., Johnson P., Phillips L., Cowley A.J., and Kinnear W.J. Inspiratory muscle endurance in patients with chronic heart failure. Heart 76 (1996) 332-336